RecruitingDiabetic Kidney DiseaseChronic Kidney Diseases
A Long-Term Follow-Up Study of Participants Exposed to REACT
Eligible age
30–80 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to evaluate the long-term safety of up to two gelatin-hydrogel formulation REACT injections given 3 to 6 months apart and delivered percutaneously into same kidney on renal function in participants with chronic kidney disease (CKD).
Sponsor: Prokidney
You may qualify if…
- ✓ The participant must have received gelatin-hydrogel formulation REACT in a previous trial (RMCL-002, REGEN-003, REGEN-004) for the treatment of chronic kidney disease and completed an end of study visit in their parent trial per protocol.
You may not qualify if…
- ✕ The participant did not receive REACT in a previous trial for the treatment of chronic kidney disease.
Where it's recruiting
Idaho
Meridian
Source: ClinicalTrials.gov · NCT05918523 · last updated 2025-05-28